Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
China Immunotech
company
About
China Immunotech is a small molecule innovative drug R&D company developing immune cell therapy technologies and products.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Industries
- Biopharma,Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Mar 1, 2018
- Number Of Employee
- 11 - 50
- Operating Status
- Active
China Immunotech is a small molecule innovative drug R&D company developing immune cell therapy technologies and products. Including CAR-T and TCR-T cell therapy with independent intellectual property rights.It was founded in March 2018 by famous immunologists.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
China Immunotech has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jul 18, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 18, 2022 | Series B | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
China Immunotech is funded by 1 investors.
Lotus Lake Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Lotus Lake Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
